SureTrader SPDR Advertisement SPDR Advertisement
Home > Boards > US Listed > Biotechs > Compugen (CGEN)

6:01AM Compugen announces results showing its CGEN-15001T drug

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
surf1944 Member Profile
 
Followed By 440
Posts 21,999
Boards Moderated 2
Alias Born 09/11/06
160x600 placeholder
Advertisement
Compugen Second Quarter 2015 Conference Call Scheduled for Tuesday, August 4, 2015 at 10:00 AM ET "Business Wire" - 7/27/2015 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 6/16/2015 11:16:46 AM
Compugen to Present at JMP Securities Life Sciences Conference in New York "Business Wire" - 6/15/2015 7:00:00 AM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 6/11/2015 9:09:05 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 6/8/2015 8:01:34 AM
Compugen to Disclose Novel Cancer Immunotherapy Target Candidate & Comprehensive Target Characterization Infrastructure at To... "Business Wire" - 6/8/2015 7:07:00 AM
Compugen to Present at Jefferies 2015 Global Healthcare Conference in New York "Business Wire" - 5/28/2015 7:00:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/27/2015 8:06:40 AM
Compugen to Hold Analyst and Investor Day in New York "Business Wire" - 5/27/2015 7:00:00 AM
Compugen Ltd. Reports First Quarter 2015 Results "Business Wire" - 5/5/2015 7:40:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 5/5/2015 7:37:05 AM
Compugen First Quarter 2015 Conference Call Scheduled for Tuesday, May 5, 2015 at 10:00 AM ET "Business Wire" - 4/28/2015 7:00:00 AM
Compugen Research Coverage Started at Jefferies Group (CGEN) "Analyst Ratings Network" - 4/23/2015 4:51:45 AM
Compugen Obtains Rights to Use Biological Systems and Materials from the US National Institutes of Health "Business Wire" - 4/14/2015 7:02:00 AM
Compugen to Present at Two Immuno-Oncology Conferences in April "Business Wire" - 4/6/2015 7:10:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 3/19/2015 7:12:17 AM
Compugen Announces Planned Relocation of Headquarters to Larger Facilities "Business Wire" - 3/19/2015 7:09:00 AM
Annual and Transition Report (foreign Private Issuer) (20-f) "Edgar (US Regulatory)" - 3/12/2015 12:09:39 PM
Compugen to Present at Two Oncology Conferences in March "Business Wire" - 3/2/2015 7:09:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/27/2015 4:08:31 PM
Compugen Expands and Strengthens Business Development Team "Business Wire" - 2/23/2015 7:04:00 AM
Compugen Ltd. Reports Fourth Quarter and Calendar 2014 Results "Business Wire" - 2/10/2015 7:10:00 AM
Report of Foreign Issuer (6-k) "Edgar (US Regulatory)" - 2/10/2015 7:01:33 AM
Compugen Presents New Results Supporting CGEN-15049 as Potential Cancer Immunotherapy Target "Business Wire" - 2/9/2015 7:14:00 AM
Compugen Fourth Quarter and Year-End 2014 Conference Call Scheduled for Tuesday, February 10, 2015 at 10:00 AM EST "Business Wire" - 2/3/2015 7:09:00 AM
surf1944   Thursday, 02/02/12 10:57:15 AM
Re: surf1944 post# 109
Post # of 145 
6:01AM Compugen announces results showing its CGEN-15001T drug may have potential for cancer immunotherapy (CGEN) 5.30 : Co announced results demonstrating the therapeutic potential of CGEN-15001T as a drug target for treatment of multiple cancers by means of monoclonal antibody ("mAb") therapy. These results indicate that CGEN-15001T is expressed on numerous types of cancer, such as carcinomas, sarcomas, melanoma and hematological cancers as well as on immune cells. These findings, together with previous results supporting its active immunomodulatory effect, 'strongly support CGEN-15001T's potential as a powerful drug target for treatment of various solid and hematological cancers, an area of great interest to the pharmaceutical industry.'


surf's up......crikey



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist